Instrument Inactif

Autres langues MusclePharm Corporation

Actions

MSLPQ

US6273352012

Sociétés holdings

Autres langues

18/10/23	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation
10/10/23	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).
03/10/23	Motion for Asset Sale Approved for MusclePharm Corporation
27/09/23	FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.
08/09/23	Stalking Horse Agreement Filed by MusclePharm Corporation
31/08/23	Musclepharm Corporation Announces Resignation of Paul Karr as Director
28/08/23	Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation
28/08/23	First Amended Disclosure Statement Approved for MusclePharm Corporation
17/08/23	Bidding Procedure Approved for MusclePharm Corporation
19/07/23	Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer
28/06/23	SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud
19/06/23	First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation
26/05/23	Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation
12/05/23	Motion for Asset Sale Filed by MusclePharm Corporation
10/05/23	First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation
16/04/23	MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.
10/04/23	First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation
08/03/23	DIP Financing Approved for MusclePharm Corporation
23/01/23	Amended DIP Financing Approved for MusclePharm Corporation
09/01/23	Interim DIP Financing Approved for MusclePharm Corporation
15/12/22	MusclePharm Corporation Filed for Bankruptcy
29/09/22	MusclePharm Appoints Gary C. Shirshac as Interim CFO
29/09/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)
29/09/22	MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial Officer
19/09/22	MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K